Thu, Mar 5, 2015, 7:52 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Array BioPharma, Inc. Message Board

  • brotherwarrior brotherwarrior Oct 9, 2013 10:10 AM Flag

    What to do?

    Should I sell it all, or is this truly a buying opportunity? Why the huge drop in 2 days?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • burnaka Oct 9, 2013 11:07 AM Flag

      That is a question only you can answer. What the stock does stocks today or tomorrow only matters if that is your time frame. I just bought yesterday, but as I stated this is a buy and hold for me. I also took a very small position figuring 50% likely hood Arry would drop to 5.50-5.64, which it did. Arry is a spec play only, and their technologies have yet to go to market. That said, their partners are some of the best in the world and have been spending MILLIONS to develop arry patents. In spite of Arry's management, internal short falls, etc., I figure Novartis and others electing to commence Phase 3 studies needs to be the focus here. If one or two drugs exit phase 3 in a couple years Arry will trade in the low double digits minimum. Short term, could retest mid 4's, but not counting on it. So do what U think best.

    • sell it all

8.24-0.060(-0.72%)Mar 5 3:59 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Geron Corporation
NASDAQThu, Mar 5, 2015 4:00 PM EST
Orexigen Therapeutics, Inc.
NASDAQThu, Mar 5, 2015 4:00 PM EST
Orbital ATK, Inc.
NYSEThu, Mar 5, 2015 4:02 PM EST